Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally – Enveric Biosciences (NASDAQ:ENVB)
Psychedelics biotech Enveric Biosciences ENVB announced positive preclinical results of its EB-003 drug candidate to be delivered via oral administration....